| scholarly article | Q13442814 |
| P356 | DOI | 10.1148/RADIOL.11101893 |
| P698 | PubMed publication ID | 21555352 |
| P50 | author | Georg A. Bjarnason | Q41630856 |
| Laurent Milot | Q56925911 | ||
| P2093 | author name string | Mostafa Atri | |
| John M Hudson | |||
| Peter N Burns | |||
| Ross Williams | |||
| Ahthavan R Sureshkumar | |||
| Brendan A Lloyd | |||
| Gordon Lueck | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microbubble | Q6839290 |
| angiogenesis inhibitor | Q574834 | ||
| renal cell carcinoma | Q1164529 | ||
| P304 | page(s) | 581-590 | |
| P577 | publication date | 2011-05-09 | |
| P1433 | published in | Radiology | Q3285690 |
| P1476 | title | Dynamic microbubble contrast-enhanced US to measure tumor response to targeted therapy: a proposed clinical protocol with results from renal cell carcinoma patients receiving antiangiogenic therapy | |
| P478 | volume | 260 |
| Q51348349 | Arterial input function calculation in dynamic contrast-enhanced MRI: an in vivo validation study using co-registered contrast-enhanced ultrasound imaging. |
| Q33760366 | Can Ultrasound With Contrast Enhancement Replace Nonenhanced Computed Tomography Scans in Patients With Contraindication to Computed Tomography Contrast Agents? |
| Q38939874 | Characteristics and Echogenicity of Clinical Ultrasound Contrast Agents: An In Vitro and In Vivo Comparison Study |
| Q45383550 | Characterization of submicron phase-change perfluorocarbon droplets for extravascular ultrasound imaging of cancer. |
| Q35843650 | Combined Radiofrequency Ablation and Double Anti-Angiogenic Protein Therapy to Increase Coagulation Efficacy: An Experimental Study in a Murine Renal Carcinoma Model |
| Q30361819 | Contrast imaging in mouse embryos using high-frequency ultrasound. |
| Q30454165 | Contrast ultrasound imaging for identification of early responder tumor models to anti-angiogenic therapy |
| Q33869697 | Contrast-Enhanced CT Density Predicts Response to Sunitinib Therapy in Metastatic Renal Cell Carcinoma Patients |
| Q53420337 | Contrast-enhanced molecular ultrasound differentiates endoglin genotypes in mouse embryos. |
| Q37924165 | Contrast-enhanced ultrasound in abdominal imaging |
| Q37970228 | Contrast-enhanced ultrasound in oncology |
| Q48378939 | Contrast-enhanced ultrasound of malignant liver lesions |
| Q36966777 | Correlation of ultrasound contrast agent derived blood flow parameters with immunohistochemical angiogenesis markers in murine xenograft tumor models |
| Q30435874 | Current status and prospects for microbubbles in ultrasound theranostics |
| Q52670034 | Detection of Early Tumor Response to Axitinib in Advanced Hepatocellular Carcinoma by Dynamic Contrast Enhanced Ultrasound. |
| Q92822660 | Differentiation of Vascular Characteristics Using Contrast-Enhanced Ultrasound Imaging |
| Q83389173 | Dynamic contrast enhanced ultrasound assessment of the vascular effects of novel therapeutics in early stage trials |
| Q38329582 | Dynamic contrast-enhanced ultrasound for quantification of tissue perfusion. |
| Q53155777 | Early prediction of tumor response to bevacizumab treatment in murine colon cancer models using three-dimensional dynamic contrast-enhanced ultrasound imaging. |
| Q30460933 | Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: a pilot study |
| Q41962463 | Evaluation of therapeutic effect of tumor-targeted therapy |
| Q37965053 | Evaluation of treatment response in patients with metastatic renal cell carcinoma: role of state-of-the-art cross-sectional imaging |
| Q49165838 | How to perform Contrast-Enhanced Ultrasound (CEUS). |
| Q91780467 | Imaging Methods for Ultrasound Contrast Agents |
| Q36567385 | Imaging techniques as predictive and prognostic biomarkers in renal cell carcinoma |
| Q51561579 | Impact of Acquisition Method and Region of Interest Placement on Inter-observer Agreement and Measurement of Tumor Response to Targeted Therapy Using Dynamic Contrast-Enhanced Ultrasound. |
| Q57477458 | In Vivo Molecular Imaging Using Low-Boiling-Point Phase-Change Contrast Agents: A Proof of Concept Study |
| Q84489684 | In vitro evaluation of the impact of ultrasound scanner settings and contrast bolus volume on time-intensity curves |
| Q38005915 | Innovation in cancer imaging. |
| Q37616769 | Intra-Animal Comparison between Three-dimensional Molecularly Targeted US and Three-dimensional Dynamic Contrast-enhanced US for Early Antiangiogenic Treatment Assessment in Colon Cancer |
| Q98175260 | Investigating the Accumulation of Submicron Phase-Change Droplets in Tumors |
| Q50859963 | In Vivo Multiparametric Ultrasound Imaging of Structural and Functional Tumor Modifications during Therapy. |
| Q58600063 | Long Term Surveillance of Renal Cell Carcinoma Recurrence Following Ablation using 2D and 3D Contrast-Enhanced Ultrasound |
| Q48194661 | Microbubble-mediated ultrasound drug-delivery and therapeutic monitoring |
| Q30420023 | Multi-planar dynamic contrast-enhanced ultrasound assessment of blood flow in a rabbit model of testicular torsion |
| Q39321118 | Nonlinear Imaging of Microbubble Contrast Agent Using the Volterra Filter: In Vivo Results. |
| Q30711589 | Outcomes in patients with metastatic renal cell cancer treated with individualized sunitinib therapy: correlation with dynamic microbubble ultrasound data and review of the literature |
| Q47130685 | Parameters for Contrast-Enhanced Ultrasound (CEUS) of Enlarged Superficial Lymph Nodes for the Evaluation of Therapeutic Response in Lymphoma: A Preliminary Study. |
| Q91383759 | Perfusion Quantification of Liver Metastases of Colorectal Cancer Treated with Anti-angiogenic-Based Therapy: Assessment of Intra- and Inter-observer Reproducibility of Parameters in Three Regions of Interest Outlining Lesions |
| Q30402324 | Predictive value of quantitative contrast-enhanced ultrasound in hepatocellular carcinoma recurrence after ablation |
| Q46845477 | Quantitative Three-Dimensional Dynamic Contrast-Enhanced Ultrasound Imaging: First-In-Human Pilot Study in Patients with Liver Metastases |
| Q30408880 | Quantitative assessment of tumor angiogenesis using real-time motion-compensated contrast-enhanced ultrasound imaging |
| Q30377881 | Quantitative correlational study of microbubble-enhanced ultrasound imaging and magnetic resonance imaging of glioma and early response to radiotherapy in a rat model. |
| Q53583557 | Quantitative dynamic contrast-enhanced ultrasound for the functional evaluation of the skeletal muscle microcirculation in systemic sclerosis. |
| Q38171376 | Recommendations for the clinical and radiological evaluation of response to treatment in metastatic renal cell cancer. |
| Q30942279 | Reprint of: Outcomes in patients with metastatic renal cell cancer treated with individualized sunitinib therapy: Correlation with dynamic microbubble ultrasound data and review of the literature |
| Q93216659 | Spatial Characterization of Tumor Perfusion Properties from 3D DCE-US Perfusion Maps are Early Predictors of Cancer Treatment Response |
| Q83887514 | The effect of preactivation vial temperature on the acoustic properties of Definity™ |
| Q49566963 | The prognostic and predictive value of vascular response parameters measured by dynamic contrast-enhanced-CT, -MRI and -US in patients with metastatic renal cell carcinoma receiving sunitinib. |
| Q36232472 | Three-dimensional Dynamic Contrast-enhanced US Imaging for Early Antiangiogenic Treatment Assessment in a Mouse Colon Cancer Model. |
| Q38096874 | Tracer-kinetic modeling of dynamic contrast-enhanced MRI and CT: a primer. |
| Q30393819 | Transcranial functional ultrasound imaging of the brain using microbubble-enhanced ultrasensitive Doppler. |
| Q30375552 | Ultrasound imaging of breast tumor perfusion and neovascular morphology. |
| Q34465123 | Validation of dynamic contrast-enhanced ultrasound in predicting outcomes of antiangiogenic therapy for solid tumors: the French multicenter support for innovative and expensive techniques study |
Search more.